$NWBI

Northwest Bancshares, Inc. Announces Redemption of Subordinated Notes

Northwest Bancshares, Inc. (Nasdaq: NWBI) said it will redeem all outstanding 4.000% fixed-to-floating rate subordinated notes due Sept. 15, 2030 on Sept. 15, 2026. The redemption price will be 100% of principal plus accrued, unpaid interest through but excluding the redemption date, paid via The Depository Trust Company.

Original reporting
Published Aug 17, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Northwest Bancshares, Inc. Announces Redemption of Subordinated Notes — source image
Decision brief

The 30-second read

$NWBINeutralLow
01

Why it matters

Redeeming subordinated notes at par plus accrued interest changes the issuer’s debt stack and future interest obligations, which can influence capital and credit perceptions.

02

Market read

This is a scheduled, issuer-specific debt redemption with defined pricing mechanics, likely more relevant to credit and capital-structure traders than equity momentum.

03

What to watch

Traders may need the note size and whether the company will issue new subordinated debt or use excess liquidity, neither of which is provided here.

Relevance 5/10Novelty 5/10Timing: redemption scheduled for Sept. 15, 2026

Background

Northwest Bancshares is the bank holding company of Northwest Bank; its common stock trades on Nasdaq under NWBI.

Company-level read

Ticker impact

$NWBINeutralMedium confidence
Context

Northwest Bancshares announced it will redeem all outstanding 4.000% fixed-to-floating subordinated notes on Sept. 15, 2026 at par plus accrued interest.

Expected impact

Likely modest, with focus on funding/capital optics rather than earnings impact.

Evidence & confidence

The article discloses the redemption date and price mechanics (100% of principal plus accrued interest) but provides no size, proceeds use, or replacement financing details that would drive a larger repricing.

Market effects

Routine bank capital management action; limited read-through to sector fundamentals without replacement issuance details.

Primarily affects the issuer’s local/regional investor base; no broader regional signal in the text.

No direct global linkage; subordinated note redemption is issuer-specific.

Counterpoint

If the company redeems without clear replacement funding, the market could interpret it as a capital optimization that may tighten future flexibility.

Key entities

  • Northwest Bancshares, Inc.

    Announced redemption of all outstanding 4.000% fixed-to-floating subordinated notes due Sept. 15, 2030.

  • The Depository Trust Company

    Payment for the redemption will be made through DTCC facilities.

Related articles

$NWBIMed

Northwest Bancshares, Inc. (NWBI): Results of Operations and Financial Condition

Northwest Bancshares, Inc. (NWBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026-06x30nwbi8ker.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE OF NORTHWEST BANCSHARES, INC. EARNINGS RELEASE FOR IMMEDIATE RELEASE Northwest Bancshares, Inc. Announces Record Second Quarter 2026 GAAP net income of $54 million, or $0.36 per diluted share Adjusted d

$BCDAMed

BioCardia, Inc. (BCDA): Other Events

BioCardia, Inc. (BCDA) filed an SEC Form 8-K — Other Events. Exhibit 99.1 BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission SUNNYVALE, Calif. – September 23, 2026 – BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of ca

$LGOMed

Largo Inc.: Largo Announces Strategic Focus on Higher-Margin Products; Provides Update on Copper-Platinum Group Metal Margins and Potential Expansion; and Further Advances Debt Restructuring

Largo Inc. (TSX: LGO) (NASDAQ: LGO) is shifting focus to higher-margin products, including high-purity vanadium and copper-PGM concentrates. Copper-PGM sales generated $4.7M in revenue with over 90% operating margins. The company is evaluating a potential expansion to double copper-PGM production in 2027. Largo also advanced debt restructuring, executing agreements with two major creditors covering 48% of its $82M commercial bank debt.

$ARXMedAI 9/10

Accelerant Holdings (ARX): Other Events

Accelerant Holdings (ARX) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Accelerant Announces Expiration of “Go-Shop” Period ATLANTA—(BUSINESS WIRE)— Accelerant Holdings (NYSE: ARX) (“Accelerant”), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced